Binghamton University

The Open Repository @ Binghamton (The ORB)
Research Days Posters 2022

Division of Research

7-14-1905

Effect of Bak and Bax on Oxidative Stress in A549 Cells
Andrew Werner
Binghamton University--SUNY

Susan Flynn
Binghamton University--SUNY

Follow this and additional works at: https://orb.binghamton.edu/research_days_posters_2022

Recommended Citation
Werner, Andrew and Flynn, Susan, "Effect of Bak and Bax on Oxidative Stress in A549 Cells" (1905).
Research Days Posters 2022. 10.
https://orb.binghamton.edu/research_days_posters_2022/10

This Book is brought to you for free and open access by the Division of Research at The Open Repository @
Binghamton (The ORB). It has been accepted for inclusion in Research Days Posters 2022 by an authorized
administrator of The Open Repository @ Binghamton (The ORB). For more information, please contact
ORB@binghamton.edu.

Monitoring the Effect of Bak and Bax on Oxidative Stress in A549 Cells in the Presence of Trichostatin A
Andrew Werner, Susan Flynn

IMPACT OF TSA ON A549 and DKO

ABSTRACT

The BCL-2 pathway, known for its role in regulating apoptosis, has been extensively studied since the discovery
of its function in 1988 [1]. Importantly, abnormalities in the function of the BCL-2 pathway have been linked to
several diseases including cancer and neurodegenerative diseases [2]. Despite new insights into the role of
BCL-2 proteins within and beyond the intrinsic apoptosis pathway, much remains unclear or debated about the
function of specific BCL-2 proteins, such as Bak and Bax. Bak and Bax are two proteins within the BCL-2
family of proteins that play a role in mitochondrial outer membrane permeabilization (MOMP), leading to the
release of cytochrome c from the mitochondria [2]. Cytochrome c then activates a cascade of caspases 3 and 9
that lead to the activation of proteases [2]. These proteases break down cellular structures leading to cell death
[2]. One thing that is unknown about Bak and Bax is their contribution to oxidative stress within cancer cells
treated with chemotherapy. One such agent is the anti-cancer drug Trichostatin A (TSA). TSA is a histone
deacetylase inhibitor (HDACi). TSA arrests cancer cells in the G2/M phase in a mitochondrial derived reactive
oxygen species (ROS) dependent matter leading to apoptosis [3]. Testing the effect of Bak and Bax on oxidative
stress in the presence of TSA can shed new light on the functions of Bak and Bax. This can lead to a new
understanding of how Bak and Bax interact with different parts the cell and could lead to a new mechanistic
model for Bak and Bax, which can be tested in future projects, including therapeutic design. Thus, I decided to
monitor how Bak and Bax modify oxidative stress within the BCL-2 pathway in A549 cell treated with
Trichostatin A.
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Figure 3. Fluorescence (a.u) of Wild-Type, Bak-Knockout, Bax-Knockout, and
Double-Knockout A549 Cells in the Presence of Trichostatin A. The corresponding
EC50 values were 38 nM, 116 nM, 14 nM, and 105 nM respectively.
Figure 4. Trichostatin A inhibit HDACs. HDACs
and HATs play opposing roles in the nucleus.
HDACs cleave acetyl groups allowing DNA to
condense, while HATs add acetyl groups to DNA,
expanding the DNA and allowing for
transcription.10 TSA inhibits HDAC, causing an
imbalance between HDACs and HATs leading to
oxidative stress in the cell.
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Figure 1. Bak and Bax in the BCL-2 pathway. The BCL-2 pathway is comprised of pro and
anti-apoptotic proteins.6 Bak and Bax are pro-apoptotic proteins (gold) that interact with the
mitochondrial outer membrane (MOM). Bak and Bax attach to the MOM and are activated
through the binding of BH3 (blue) so they can permeabilize the MOM.7 This leads to the release
of cytochrome c (green), initiating a caspase cascade that leads to cell death.8,9
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Figure 2. Treatment of Wild-Type and Double-Knockout A549 cells with
Trichostatin A. A cell viability assay was performed using WT and DKO A549 cells
treated with varying concentrations of TSA. An IC50 value was then obtained for each cell
line. A CellRox® assay was performed to determine the overall oxidative stress in both
the WT and DKO A549 cells. Images of WT and DKO A549 were then taken using
fluorescent microscopy and used to calculate the fluorescent intensity per pixel.
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Figure 2: Normalized Fluorescence of Wild-type and Knockout Cell Lines
in Presence of 1 uM TSA. The bak knockout and double knockout cell lines
showed increased fluorescence over vehicle controls, while the wild-type and
bax knockout showed no significant increase over the vehicle controls. This
suggests that the absence of bak increases oxidative stress or bak decreases
oxidative stress. The oxidative stress was monitored post 24 hours utilizing the
CellROX® Deep Red reagent and fluorescent microscopy and normalized
using an SRB assay.

on oxidative stress upon treatment with a dose
response of chemotherapy to wild-type and modified lung carcinoma cells. Wild-type
and double-knockout (DKO) A549 cells were treated with a range of TSA, a chemotherapy
agent, concentrations (1-100 μM) and a vehicle control. TSA and incubated for either 24 or
48 hours. The oxidative stress was monitored post 24 hours and 48 hours utilizing the
CellROX® Deep Red reagent and fluorescent microscopy (20X objective, DMi8 Leica
filter Ex. 644nm Em. 665nm, 100ms exposure). Further analysis will yield a change in
oxidative stress as a result of the chemotherapy agent providing insight for future
treatments and understanding of the BCL-2 pathway.
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Figure 6. Further investigation of the impact of Bak and Bax on oxidative stress and
chemotherapy treatment. Further work could include testing HDAC activity to see if Trichostatin A
is acting as a true HDAC inhibitor. This will also allow for novel comparison investigations with
other chemotherapy treatments. Additionally, it has been shown that Bak plays a role in peroxisome
permeabilization [4]. It is possible that the release of catalase from the peroxisome. following
permeabilization from Bak could decrease reactive oxygen species in the cytosol. This hypothesis is
consistent with the results obtained. Further research could confirm this. It is also possible that
reduced peroxisome biogenesis could increase oxidative stress by disrupting normal cellular
metabolism. However, this hypothesis does not appear to be supported. In addition, we could test
different cell lines to see if they respond in a similar fashion to treatment with Trichostatin A.
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